Kai Beckmann

Merck Sells Its CDMO Business to Lonza

Merck is streamlining its portfolio in the Life Science division and selling its CDMO business to Lonza.

Merck Acquires Life Sciences Company Bio-Techne

Merck has agreed to acquire Bio-Techne in an all-cash deal valuing the company at approximately $11.3 billion.

Merck: Beckmann to Succeed Garijo as CEO

Kai Beckmann to succeed Belén Garijo as new Chairman of the Executive Board and CEO of Merck in May 2026.

Merck KGaA and Universal Display Link on OLEDS